List of Brand Recomended for "For the treatment of Pediatric Patients with High-Risk Neuroblastoma who Acheive at least a Partial Response to Prior First-Line Multiagent Multimodality Therapy ".
1 Result founds.
Brand Name: UNITUXIN*
Manufacture Name: UNITED THERAPEUTICS CORPORATION INC.
Compositions:
Dinutuximab- mg,
